Quantifying Neck Fibrosis and Its Functional Implications: Development of the Neck Fibrosis Scale.
Head and neck cancer
fibrosis
patient reported outcomes
survivorship
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
21
08
2021
received:
06
07
2021
accepted:
29
09
2021
pubmed:
16
10
2021
medline:
13
4
2022
entrez:
15
10
2021
Statut:
ppublish
Résumé
Despite increasing recognition of the importance of functional outcomes for patients with head and neck cancer, post-treatment neck fibrosis remains poorly understood. We sought to develop and validate a patient reported outcome measure for head and neck cancer patients with neck fibrosis. Prospective multiphase cross-sectional study. To guide instrument development, we employed the World Health Organization International Classification of Functioning, Disability and Health as our conceptual framework. Items were generated using a composite strategy consisting of patient focus groups, literature review, and expert opinion from a multidisciplinary group. Candidate items were reduced through the item impact method. Preliminary psychometric properties of the finalized instrument were evaluated through measures of internal consistency, test-retest reliability, and construct validity. Four in person focus groups were held with 13 head and neck cancer patients. The process of item generation led to 221 relevant citations and 68 unique items. An additional 17 items were identified from review of existing neck disability questionnaires and expert opinion. A draft instrument with 25 candidate items was generated and reduced to its final 15-item scale using item impact method. Early psychometric testing revealed excellent internal consistency (Cronbach's alpha = 0.95) and test-retest reliability [ICC = 0.95]. Internal consistency at the item level was good (>0.7) for 11/15 individual items. Four separate constructs were evaluated. Three of the four constructs matched our a priori hypotheses. The Neck Fibrosis Scale demonstrates preliminary reliability and validity for discriminate use. Further research is needed to confirm dimensionality and assess responsiveness. NA Laryngoscope, 132:1015-1021, 2022.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1015-1021Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
© 2021 The American Laryngological, Rhinological and Otological Society, Inc.
Références
Hammerlid E, Silander E, Hörnestam L, et al. Health-related quality of life three years after diagnosis of head and neck cancer-a longitudinal study. Head Neck 2001;23:113-125.
Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the MD Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001;127:870-876.
Gorlin RJ, Cohen MM Jr, Hennekam RC. Syndromes of the Head and Neck. Oxford, United Kingdom: Oxford University Press; 2001.
Tschiesner U, Schuster L, Strieth S, et al. Functional outcome in patients with advanced head and neck cancer: surgery and reconstruction with free flaps versus primary radiochemotherapy. Eur Arch Otorhinolaryngol 2012;269:629-638.
Van Wilgen CP, Dijkstra PU, van der Laan BF, et al. Morbidity of the neck after head and neck cancer therapy. Head Neck 2004;26:785-791.
Bentzen SM, Thames HD, Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother Oncol 1989;15:267-274.
Davis AM, Dische S, Gerber L, Saunders M, Leung SF, O'Sullivan B. Measuring postirradiation subcutaneous soft-tissue fibrosis: state-of-the-art and future directions. Semin Radiat Oncol 2003;13:203-213.
PROMIS standards. Available at: https://www.mcgill.ca/can-pro-network/files/can-pro-network/promisstandards_vers2.0_final.pdf. Accessed April 18, 2021.
Prinsen CA, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res 2018;27:1147-1157.
Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. CMAJ 1986;134:889.
Streiner DL, Norman GR, Cairney J. Health Measurement Scales: A Practical Guide to Their Development and Use. USA: Oxford University Press; 2015.
Omdl S, World Health Organization, World Health Organization Staff. International Classification of Functioning, Disability and Health. Geneva, Switzerland: World Health Organization; 2001.
Noel CW, Sutradhar R, Li Q, et al. Association of immigration status and Chinese and south Asian ethnicity with incidence of head and neck cancer. JAMA Otolaryngol Head Neck Surg 2020;146:1125-1135.
Noel CW, Sutradhar R, Li Q, et al. Chinese and south Asian ethnicity, immigration status and head and neck cancer outcomes: a population based study. Oral Oncol 2021;113:105118.
Gudi S, O'Sullivan B, Hosni A, et al. Outcome and treatment toxicity in east-Indian versus white-Canadian patients with oral cavity cancer following postoperative (chemo-) radiotherapy delivered under similar multidisciplinary care: a propensity-matched cohort study. Oral Oncol 2021;120:105419.
Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res 2005;15:1277-1288.
Schellingerhout JM, Verhagen AP, Heymans MW, et al. Measurement properties of disease-specific questionnaires in patients with neck pain: a systematic review. Qual Life Res 2012;21:659-670.
Taylor RJ, Chepeha JC, Teknos TN, et al. Development and validation of the neck dissection impairment index: a quality of life measure. Arch Otolaryngol Head Neck Surg 2002;128:44-49.
Dische S. The uniform reporting of treatment-related morbidity. Semin Radiat Oncol 1994;4:112-118.
Cox JD. Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
Pavy J, Denekamp J, Letschert J, et al. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 1995;35:11-15.
Deng J, Ridner SH, Murphy BA, et al. Preliminary development of a lymphedema symptom assessment scale for patients with head and neck cancer. Support Care Cancer 2012;20:1911-1918.
de Almeida JR, Vescan AD, Gullane PJ, et al. Development of a disease-specific quality-of-life questionnaire for anterior and central skull base pathology-the skull base inventory. Laryngoscope 2012;122:1933-1942.
JRD A, Alexander AJ, Shrime MG, et al. Development and preliminary validation of the lip reanimation outcomes questionnaire. Otolaryngology Head Neck Surg 2010;143:361-366.
Juniper EF, Guyatt GH, Streiner DL, et al. Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol 1997;50:233-238.
Hoyle RH, Harris MJ, Judd CM. Research Methods in Social Relations. Hoboken, NJ: Wiley-Blackwell; 2002.
Larjani S, Monteiro E, Witterick I, et al. Preliminary cross-sectional reliability and validity of the skull base inventory (SBI) quality of life questionnaire. J Otolaryngol Head Neck Surg 2016;45:45.
Nunnally JC. Psychometric Theory. 2d ed., New York, NY: McGraw-Hill; 1978.
Capuano-Pucci D, Rheault W, Aukai J, et al. Intratester and intertester reliability of the cervical range of motion device. Arch Phys Med Rehabil 1991;72:338-340.
Chin CJ, Franklin JH, Turner B, et al. A novel tool for the objective measurement of neck fibrosis: validation in clinical practice. J Otolaryngol Head Neck Surg 2012;41:320-326.
Lund A. Pearson Product-Moment Correlation. Long Eaton, Nottingham: Laerd Statistics; 2013.
Moloney EC, Brunner M, Alexander AJ, et al. Quantifying fibrosis in head and neck cancer treatment: an overview. Head Neck 2015;37:1225-1231.
Deng J, Ridner SH, Wells N, et al. Development and preliminary testing of head and neck cancer related external lymphedema and fibrosis assessment criteria. Eur J Oncol Nurs 2015;19:75-80.
Deng J, Dietrich MS, Niermann KJ, et al. Refinement and validation of the head and neck lymphedema and fibrosis symptom inventory. Int J Radiat Oncol Biol Phys 2021;109:747-755.
Kataru RP, Wiser I, Baik JE, et al. Fibrosis and secondary lymphedema: chicken or egg? Transl Res 2019;209:68-76.
Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chronic Dis 1985;38:27-36.